Compare GKOS & MGY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GKOS | MGY |
|---|---|---|
| Founded | 1998 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 5.2B |
| IPO Year | 2015 | 2017 |
| Metric | GKOS | MGY |
|---|---|---|
| Price | $122.45 | $29.34 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 15 |
| Target Price | ★ $126.92 | $30.36 |
| AVG Volume (30 Days) | 779.2K | ★ 2.1M |
| Earning Date | 04-29-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 2.18% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.24 |
| Revenue | $507,442,000.00 | ★ $1,311,845,000.00 |
| Revenue This Year | $23.32 | $14.65 |
| Revenue Next Year | $27.43 | $1.99 |
| P/E Ratio | ★ N/A | $121.58 |
| Revenue Growth | ★ 32.33 | N/A |
| 52 Week Low | $73.16 | $21.07 |
| 52 Week High | $148.11 | $32.76 |
| Indicator | GKOS | MGY |
|---|---|---|
| Relative Strength Index (RSI) | 40.86 | 49.55 |
| Support Level | $79.59 | $21.65 |
| Resistance Level | $123.09 | $29.69 |
| Average True Range (ATR) | 6.56 | 0.83 |
| MACD | -1.43 | 0.06 |
| Stochastic Oscillator | 5.60 | 52.67 |
Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.
Magnolia Oil & Gas Corp is an independent oil and natural gas company engaged in the acquisition, development, exploration, and production of oil, natural gas, and natural gas liquids (NGL) reserves. The company's oil and natural gas properties are located in Karnes County and the Giddings area of South Texas, where it targets the Eagle Ford Shale and Austin Chalk formations. It focuses on generating value for shareholders by delivering steady, moderate annual production growth resulting from its capital spending philosophy. The company operates in only one segment and derives the majority of its revenue from the sale of crude oil, natural gas, and natural gas liquids (NGLs).